Covaxin Phase 3 Trials - Search Videos

Covaxin shows 77.8% efficacy in phase 3 trial data: All you need to know | Covid

Covaxin shows 77.8% efficacy in phase 3 trial data: All you need to …

Hindustan TimesMohammad Shuaib

Covaxin, the Covid-19 vaccine, being developed by Bharat Biotech is now undergoing phase-3 trials. The company is also working on another vaccine for Covid-19. The new vaccine would be in the form of nasal drops and can be ready by next year. Bharat Biotech is the only vaccine company in the world which has BSL3 production facility. Covaxin is being developed by Bharat Biotech, in collaboration with ICMR and National Institute of Virology. | The Times of India

Covaxin, the Covid-19 vaccine, being developed by Bharat Biotec…

29.4K viewsNov 16, 2020

FacebookThe Times of India

AMU begins phase 3 trials of COVAXIN; Vice Chancellor registers as first volunteer - BusinessToday

AMU begins phase 3 trials of COVAXIN; Vice Chancellor registe…

businesstoday.in

Dr Randeep Guleria, Director, AIIMS says Covaxin efficacy data is encouraging but trails will continue. This is an interim Phase 3 result based on 43 infections, but for final results, 130 infections need to be studied. But Dr Guleria says this will go a long way in promoting the vaccine program in the country. | NDTV

Dr Randeep Guleria, Director, AIIMS says Covaxin efficacy data is enco…

17.7K viewsMar 3, 2021

Bharat Biotech starts phase III trials for Covaxin

Bharat Biotech starts phase III trials for Covaxin

timesnownews.com

Covaxin approved for phase 2/3 trials on children

Covaxin approved for phase 2/3 trials on children

India TodayIndia Today Television

Bharat Biotech Completed Phase 2 and 3 Trials Of Covaxin For Children Under 18 Years #BharatBiotech #Covaxin #NTVNews #NTVTelugu | Ntv Telugu

Bharat Biotech Completed Phase 2 and 3 Trials Of Covaxin For Childr…

1.1K viewsSep 22, 2021

FacebookNtv Telugu

Covaxin phase 4 trials to be conducted soon, phase 3 data to b…

Covaxin Phase 1 Trial Clears Lancet Review, Phase 3 Trial Ongoing |

Covid-19 vaccine: Expert panel seeks clarifications from Bharat Bi…

India TodayIndia Today Web Desk

Covaxin, the homegrown coronavirus vaccine that was auth…

27.9K viewsMar 9, 2021

Bharat BioTech's Covaxin phase III trials face shortage of volunteers i…

India's first indigenous vaccine against COVID-19, showed enhanc…

36.5K viewsJan 22, 2021

Bharat Biotech starts phase III trials for Covaxin; will it be worlds chea…

Covaxin gets nod for phase 2/3 trials on 2-18 year-olds: Why it is signifi…

Hindustan TimesPrajwal Pariyar

Bharat Biotech 'thousands of volunteers short' for ongoing Cov…

Covaxin shots reach Ahmedabad hospital for phase-3 trials

Covaxin crosses half-way mark in phase 3 clinical trials with 13,000 …

Covaxin Recommended For Next Phase Of Trials For 2-18 Age Grou…

Govt expert panel approves Bharat Biotech's Covaxin phase-3 trials e…

Bharat Biotech claims 77.8% efficacy for Covaxin in Phase 3 trials

India TodayIndia Today Television

Covaxin Phase 3 Data Shows 77.8% Efficacy, Says Lancet

Indian Council of Medical Research (ICMR) shared #COVAXIN phase-…

2.1K viewsDec 25, 2020

Covaxin's phase 3 results soons, says Bharat Biotech

Bharat Biotech's Covaxin phase 3 data shows 77.8 pc efficacy again…

Covaxin 77.8% Effective In Phase 3 Trial Data: Sources |

NDTVSukirti Dwivedi

Phase 3 Trial in US Shows India's Covaxin is 100% Effective Agains…

Covaxin's Phase 2/3 trial on children to be completed by September

Phase 3 clinical trials for Oxford coronavirus vaccine begins

COVAXIN: India's first COVID-19 vaccine developed by Bharat Biot…

See more videos